期刊文献+

呼吸机相关性肺炎的诊治进展 被引量:12

Current Status in Diagnosis and Treatment of Ventilator-associated Pnemnonia
下载PDF
导出
摘要 呼吸机相关肺炎是机械通气的常见并发症,也是院内感染的常见类型。其发生率和死亡率高,严重影响重症患者的救治成功率,已经成为呼吸机依赖和重症患者死亡的重要原因之一。及时诊断和采取合理的治疗措施是改善患者预后的关键。我们参考国内外相关研究文献,该文主要综述目前呼吸机相关肺炎的诊断和治疗进展,尤其是临床的诊断和抗生素的治疗。 Ventilator-associated pnemnonia(VAP)was common in the patients of mechanical ventilated and also common type of nosocomial infection.Ventilator-associated pneumonia also had high incidence and mortality in critical patients who had got ventilation.And to get early diagnosis and advisable treatment is the key to improving the prognosis of VAP patients.So we summarized the concerned researched finding and publishing with CVP.We just focused on the current progression of diagnosis and use of antibiotics for VAP.
作者 王雪 郭利涛
出处 《医学与哲学(B)》 2017年第2期32-34,54,共4页 Medicine & Philosophy(B)
关键词 呼吸机相关性肺炎 进展 诊断 抗生素 ventilator-associated pneumonia progression diagnosis antibiotics
  • 相关文献

参考文献5

二级参考文献66

  • 1王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 2Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin -- United States, 2002. MMWR Morb Mortal Wkly Rep, 2002,51: 565-567.
  • 3Appelbaum PC. MRSA the tip of the iceberg. Clin Microbioi Infect, 2006,12 Suppl 2 ;S3-10.
  • 4Moher D, Pham B, Jones A,et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet, 1998,352 : 609-613.
  • 5Vickers A, Goyal N, Harland R, et al. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials, 1998,19 : 159-166.
  • 6Egger M, Davey Smith G, Schneider M,et al, Bias in meta- analysis detected by a simple, graphical test. BMJ, 1997, 315 : 629-634.
  • 7Wunderink RG, Mendelson MH, Somero MS, et al. Early microbiological response to linezolid vs vancomyein in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest, 2008, 134 : 1200-1207.
  • 8Kohno S, Yamaguchi K, Aikawa N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin resistant Staphylococcus aureus in Japan. JAntimicrob Chemother, 2007,60:1361-1369.
  • 9Sharpe JN, Shively EH, Polk HC Jr. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg, 2005,189:425-428.
  • 10Weigelt J, Itani K, Stevens D, et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother, 2005,49: 2260- 2266.

共引文献173

同被引文献150

引证文献12

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部